Education
About Us
Working with TipRanks
Follow Us
InDex Pharmaceuticals Holding AB (SE:FLERIE)
:FLERIE
FLERIE Stock Chart & Stats
kr39.05
-kr0.13(-0.28%)
At close: 4:00 PM EST
kr39.05
-kr0.13(-0.28%)
Day’s Range― - ―
52-Week Rangekr37.21 - kr51.51
Previous CloseN/A
Volume1.84K
Average Volume (3M)13.18K
Market Cap
kr3.01B
Enterprise Valuekr2.78B
Total Cash (Recent Filing)kr737.30M
Total Debt (Recent Filing)kr700.00K
Price to Earnings (P/E)―
Beta0.14
Next Earnings
Jan 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.78
Shares Outstanding77,455,960
10 Day Avg. Volume8,046
30 Day Avg. Volume13,183
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)0.79
Price to Sales (P/S)33086.16
P/FCF Ratio-194.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FLERIE FAQ
What was InDex Pharmaceuticals Holding AB’s price range in the past 12 months?
InDex Pharmaceuticals Holding AB lowest stock price was kr37.21 and its highest was kr51.51 in the past 12 months.
What is InDex Pharmaceuticals Holding AB’s market cap?
InDex Pharmaceuticals Holding AB’s market cap is kr3.01B.
When is InDex Pharmaceuticals Holding AB’s upcoming earnings report date?
InDex Pharmaceuticals Holding AB’s upcoming earnings report date is Jan 21, 2026 which is in 64 days.
How were InDex Pharmaceuticals Holding AB’s earnings last quarter?
InDex Pharmaceuticals Holding AB released its earnings results on Oct 22, 2025. The company reported -kr1.781 earnings per share for the quarter, missing the consensus estimate of N/A by -kr1.781.
Is InDex Pharmaceuticals Holding AB overvalued?
According to Wall Street analysts InDex Pharmaceuticals Holding AB’s price is currently Overvalued.
Does InDex Pharmaceuticals Holding AB pay dividends?
InDex Pharmaceuticals Holding AB does not currently pay dividends.
What is InDex Pharmaceuticals Holding AB’s EPS estimate?
InDex Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InDex Pharmaceuticals Holding AB have?
InDex Pharmaceuticals Holding AB has 77,455,960 shares outstanding.
What happened to InDex Pharmaceuticals Holding AB’s price movement after its last earnings report?
InDex Pharmaceuticals Holding AB reported an EPS of -kr1.781 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.036%.
Which hedge fund is a major shareholder of InDex Pharmaceuticals Holding AB?
Currently, no hedge funds are holding shares in SE:FLERIE
Company Description
InDex Pharmaceuticals Holding AB
InDex Pharmaceuticals Holding AB (FLERIE) is a biotechnology company focused on developing innovative treatments for inflammatory and autoimmune diseases. The company specializes in the research and commercialization of its proprietary drug candidates, particularly those targeting the modulation of immune responses. Through its advanced peptide-based therapies, InDex aims to address unmet medical needs in various therapeutic areas, leveraging its expertise in drug development and clinical trials to bring new solutions to market.
Technical Analysis
SynAct Pharma AB
―
C-Rad AB Class B
―
Vicore Pharma Holding AB
―
Guard Therapeutics International AB
―
Xspray Pharma AB
―